A randomized, double-blind study comparing the efficacy and safety of Trazodone OAD and venlafaxine XR in the treatment of patients with Major Depressive Disorder.

Trial Profile

A randomized, double-blind study comparing the efficacy and safety of Trazodone OAD and venlafaxine XR in the treatment of patients with Major Depressive Disorder.

Completed
Phase of Trial: Phase III

Latest Information Update: 15 Jun 2016

At a glance

  • Drugs Trazodone (Primary) ; Venlafaxine
  • Indications Major depressive disorder
  • Focus Registrational; Therapeutic Use
  • Sponsors Angelini Group
  • Most Recent Events

    • 29 Dec 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 17 Aug 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top